Cancer research: New US patent to Swedish researchers

The ideas that have been patented deal with improved ways of detecting illness signals in blood samples. Through their research they have come up with a way of detecting very low levels of illness-related substances, such as, for instance, prostate-specific antigen, something that is important when a follow-up is carried out after surgery. Another possibility that comes with the idea is the ability to detect multiple markers simultaneously.

As a result, diagnostics for, for instance, prostate cancer can be improved.
The patent has been given the name “Detection conjugate” and will be printed and published in the US sometime during the first months of 2014. The patent adds to an earlier Swedish patent.

– This is a major step towards the commercialisation of our ideas concerning diagnostics and, generally speaking, an important recognition”, says Alf Månsson.

“In addition, since we handed in our Swedish patent application, we have published a number of scientific articles which have shown that our ideas can be put into practice, for instance in J Nanobiotechnology and Nano Letters.

For further information, please contact
Alf Månsson, professor of physiology, phone: +4670-886 62 43
Sven Tågerud, professor of pharmacology, phone: +46480-446 256
Christina Dahlgren, senior press officer, phone: +4670-572 26 56
Weitere Informationen:
http://www.jnanobiotechnology.com/content/11/1/14 Article in J Nanobiotechnology
http://pubs.acs.org/doi/full/10.1021/nl404032k Article in Nano Letters